title: A nitrergic secretomotor neurotransmitter in the chloride secretory response to serotonin.
abstract: The neural secretory response to serotonin is mediated by enteric nerve-based 5-HT3 receptors via a nonadrenergic, noncholinergic neurotransmitter. We hypothesize that nitric oxide (NO) is this neurotransmitter, acting through cGMP at the secretory cell level to induce chloride secretion in the rat distal colon. Chambered colon was exposed to the 5-HT3 agonist, 2-methyl-5-HT, in the presence and absence of potent neural nitric oxide synthase (nNOS) inhibitors, quantifying changes in short-circuit current (delta I(SC)). Isotopic chloride efflux was measured in isolated colonocytes treated with a NO* donor (DNO) or cGMP analogue in the presence and absence of a guanylyl cyclase antagonist. Cyclic GMP production was quantified in both models. Pretreatment with potent nNOS antagonists significantly reduced the concentration-dependent 2-methyl-5-HT-induced delta I(SC). 2-Methyl-5-HT caused significant cGMP production. DNO induced cGMP production and cGMP-dependent chloride efflux in colonocyte populations. These data indicate that NO is a secretomotor neurotransmitter in response to serotonin.
authors.affiliation: Department of Surgery, Medical College of Virginia at Virginia Commonwealth University, Richmond, Virginia 23298, USA.
authors.forename: Brian N
authors.initials: BN
authors.lastname: King
authors.forename: Michael C
authors.initials: MC
authors.lastname: Stoner
authors.forename: Sheikh M
authors.initials: SM
authors.lastname: Haque
authors.forename: John M
authors.initials: JM
authors.lastname: Kellum
mesh_terms: D000818:Animals; D002712:Chlorides / Q000378:metabolism*; D003106:Colon / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism* / Q000502:physiology; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000096:biosynthesis; D004553:Electric Conductivity; D004791:Enzyme Inhibitors / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D009569:Nitric Oxide / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000494:pharmacology; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D052248:Nitric Oxide Synthase Type I; D051381:Rats; D017207:Rats, Sprague-Dawley; D012701:Serotonin / Q000031:analogs & derivatives* / Q000494:pharmacology*; D017366:Serotonin Receptor Agonists / Q000494:pharmacology
chemical_list: D002712:Chlorides; D004791:Enzyme Inhibitors; D020030:Nitric Oxide Donors; D017366:Serotonin Receptor Agonists; D009569:Nitric Oxide; D012701:Serotonin; C045918:2-methyl-5-HT; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I; C496322:Nos1 protein, rat; D006152:Cyclic GMP